Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients

The prognostic significance of suPAR in various kidney diseases has recently been demonstrated. Its role in transplantation-specific outcomes is still largely unknown. Therefore, we prospectively investigated the prognostic relevance of suPAR in patients before and one year after kidney transplantat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jehn, Ulrich, Schütte-Nütgen, Katharina, Henke, Ute, Pavenstädt, Hermann, Suwelack, Barbara, Reuter, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880993/
https://www.ncbi.nlm.nih.gov/pubmed/33580120
http://dx.doi.org/10.1038/s41598-021-83333-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880993/
https://www.ncbi.nlm.nih.gov/pubmed/33580120
http://dx.doi.org/10.1038/s41598-021-83333-7

Ejemplares similares